BRANDI BROWNING: Open Payments
NPI 1164166823 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$521 in 29 payments from 6 companies in 2025. Trend: 2023 $18 · 2024 $144 · 2025 $521
Food & beverage: $521
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $336 |
| Vanda Pharmaceuticals Inc. | 4 | $92 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Lilly USA, LLC | 1 | $15 |
Products named: VRAYLAR, FANAPT, UBRELVY, AIRSUPRA, TRELEGY ELLIPTA, QULIPTA, CAPLYTA, MOUNJARO.
Industry payments across KY — which companies pay providers there.
